Search filters

List of works by Evon Poon

Association with Aurora-A Controls N-MYC-Dependent Promoter Escape and Pause Release of RNA Polymerase II during the Cell Cycle.

scientific article published in December 2017

Combined MYC and P53 defects emerge at medulloblastoma relapse and define rapidly progressive, therapeutically targetable disease

scientific article published on 12 January 2015

Combined inhibition of Aurora-A and ATR kinase results in regression of <i>MYCN</i>-amplified neuroblastoma

scientific article published on 11 February 2021

Cyclin-Dependent Kinase Inhibitor AT7519 as a Potential Drug for MYCN-Dependent Neuroblastoma

scientific article published on 22 July 2015

Detection of the prodrug-activating enzyme carboxypeptidase G2 activity with chemical exchange saturation transfer magnetic resonance.

scientific article

Enhancer invasion shapes MYCN-dependent transcriptional amplification in neuroblastoma.

scientific article published on 29 January 2018

Glycogen synthase kinase 3 controls migration of the neural crest lineage in mouse and Xenopus

scientific article published on 19 March 2018

Indisulam targets RNA splicing and metabolism to serve as a therapeutic strategy for high-risk neuroblastoma

scientific article published on 16 March 2022

MRI Imaging of the Hemodynamic Vasculature of Neuroblastoma Predicts Response to Antiangiogenic Treatment

scientific article published on 15 March 2019

Small Molecule Inhibitors of Aurora-A Induce Proteasomal Degradation of N-Myc in Childhood Neuroblastoma

scientific article published on 08 August 2016

Small molecule inhibitors of aurora-a induce proteasomal degradation of N-myc in childhood neuroblastoma

scientific article published on 8 July 2013

Structural basis of N-Myc binding by Aurora-A and its destabilization by kinase inhibitors

scientific article

Sulfopin is a covalent inhibitor of Pin1 that blocks Myc-driven tumors in vivo

scientific article published on 10 May 2021

Targeting the hypoxia-inducible factor (HIF) pathway in cancer.

scientific article published on 27 August 2009

The ALK(F1174L) mutation potentiates the oncogenic activity of MYCN in neuroblastoma

scientific article published in July 2012